Loading provider…
Loading provider…
Pediatrics Physician in Chapel Hill, NC
NPI: 1417037987Primary Practice Location
UNC HOSPITALS
101 Manning Dr, Chapel Hill, NC
Primary Employer
UNC Faculty Physicians
uncmedicalcenter.org
HQ Phone
Get MD David's Phone Numberphone_androidMobile
Get MD David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
NC State Medical License
1992 - 2026
MD State Medical License
1987 - 1993
WV State Medical License
1985 - 1991

American Board of Allergy and Immunology
Allergy & Immunology

American Board of Allergy and Immunology
Diagnostic Laboratory Immunology

American Board of Pediatrics
Pediatrics
National Institutes of Health Clinical Center
Fellowship • Allergy and Immunology
1988 - 1992
West Virginia University
Residency • Pediatrics
1984 - 1987
Pharmacology and Toxicology
Until 1984
B.A. • Biology
Until 1980
West Virginia University School Of Medicine
medicine.wvu.edu
Medical School
Until 1984
Src-Mediated EGF Receptor Activation Regulates Ozone-Induced Interleukin 8 Expression in Human Bronchial Epithelial Cells
Authors: Weidong Wu, Phillip A. Wages, Robert B. Devlin, David Diaz-Sanchez, David B. Peden, James M. Samet
Publication Date: 2014-10
Advances in environmental and occupational disorders in 2012.
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: Immune Tolerance Network (ITN), Rho Federal Systems Division, Inc.
Intervention / Treatment: BIOLOGICAL: Placebo, BIOLOGICAL: Moderna COVID-19 Vaccine, BIOLOGICAL: Pfizer-BioNTech COVID-19 Vaccine
Lead Sponsor: University of North Carolina, Chapel Hill
Intervention / Treatment: DIAGNOSTIC_TEST: To assess for development of IgG antibodies against SARS-CoV2
Lead Sponsor: University of North Carolina, Chapel Hill
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Intervention / Treatment: DEVICE: 3% Hypertonic Saline, DEVICE: 7% Hypertonic Saline, DRUG: Salbutamol